U.S. Insurance Stock News

eBay has joined the newly launched Shared AI License Foundation as a founding board observer. The foundation brings together companies such as Anthropic, IBM, Meta, and Microsoft to share access to foundational AI patents. The initiative aims to support faster AI development through a shared patent framework. For investors watching NasdaqGS:EBAY, this move ties directly into how the company may use AI to refine its marketplace and improve user experience. The stock trades at $95.58, with...

If you are wondering whether Tetra Tech's current share price offers good value or if you might be overpaying for quality, this article walks through the key valuation checks that matter most. The stock last closed at US$30.85, with a 0.7% decline over 7 days, an 8.1% decline over 30 days, and an 8.3% decline year to date. The 1 year, 3 year, and 5 year returns sit at 6.2%, 7.2%, and 16.9% respectively. Recent price movements are occurring against a backdrop of ongoing investor interest in...

Cencora stock reaction and recent performance Cencora (COR) has recently drawn investor attention after a period of weaker share performance, with the stock down about 8% over the past month and roughly 4% over the past 3 months. At a last close of US$322.46 and a market value of about US$63.2b, the company pairs large scale distribution operations with continued revenue and net income growth on an annual basis. See our latest analysis for Cencora. While the recent 30 day share price return...

How Globalstar’s Recent Performance Frames the Investment Question Globalstar (GSAT) has drawn fresh attention after a period where its share price moved about 24% over the past month and about 22% over the past 3 months, prompting investors to reassess the satellite operator. See our latest analysis for Globalstar. That recent 24.4% 1 month share price return and 21.9% 3 month share price return sit alongside a 278.9% 1 year total shareholder return, suggesting momentum has been strong, even...

Duolingo (DUOL) is drawing attention after reporting strong revenue growth that exceeded analyst expectations, while signaling a focus on user growth over near term profitability, and facing legal scrutiny following investor losses. See our latest analysis for Duolingo. The recent focus on user growth, heavier AI investment and the legal investigation has coincided with a 48.7% year to date share price return decline and a 71.44% 1 year total shareholder return decline. This suggests that...

Prairie Operating Co. reported past full-year 2025 results on March 30, 2026, showing revenue of US$241.65 million versus US$7.94 million a year earlier and moving from a net loss of US$40.91 million to net income of US$32.05 million, alongside detailed production disclosure. Management also issued production and earnings guidance for 2026, targeting average daily output of 25,500–27,500 Boe/d and net income of US$55 million to US$65 million, highlighting how operational scale now ties...

Over the past week, Textron Aviation secured fresh defense and special-mission business with Belgium and the Peruvian Army, while also unveiling an in‑flight operable door for the Cessna SkyCourier that expands its military, humanitarian and commercial mission roles from around 2028. This combination of new international government customers and mission‑enhancing product features underlines how Textron is deepening its role in specialized defense and relief aviation. We’ll now examine how...

Wondering if Inspire Medical Systems at around US$56.69 is a bargain or a value trap? This article focuses on what the current price really implies about the stock. The share price has seen mixed recent moves, with a 3.1% gain over the last 7 days, a 4.6% decline over 30 days, and year to date and 1 year returns of 38.6% and 60.8% declines respectively. Recent coverage has focused on how the share price performance over multiple time frames compares to broader market and industry moves,...

Why Scotts Miracle-Gro is drawing fresh attention Scotts Miracle-Gro (SMG) is back on investors’ radar after recent share price swings and updated performance metrics. This is prompting a closer look at how its lawn and garden business aligns with current portfolio goals. See our latest analysis for Scotts Miracle-Gro. Recent trading has been choppy, with a 1-day share price return of a 2.01% decline and a 7-day share price return of a 2.10% decline. However, the 1-year total shareholder...

Q4 results and Exzeo IPO shift focus to HCI Group HCI Group (HCI) is back on investors’ radar after Q4 revenue grew 52.1% year on year, earnings reached record levels for 2025, and the company completed the IPO of its technology platform, Exzeo. See our latest analysis for HCI Group. Despite the strong Q4 update and the Exzeo IPO, momentum in HCI Group’s share price has cooled. The 30 day share price return shows a decline of 4.21%, and the year to date share price return shows a decline of...

Context for CME Group after recent share performance CME Group (CME) shares have eased in the month and past week, with returns of about a 2% decline over 30 days and a 1% decline over 7 days, while the past 3 months show a roughly 14% gain. See our latest analysis for CME Group. The recent 1 day and 30 day share price declines sit against a stronger backdrop, with the 90 day share price return of 13.9% and 1 year total shareholder return of 20.1% pointing to momentum that has built over a...

Leadership move in aerospace and defense investment banking Oppenheimer Holdings (OPY) shares are in focus after subsidiary Oppenheimer & Co. appointed Bill Farmer as Managing Director and Head of Aerospace & Defense Technology Investment Banking, a role centered on mergers, acquisitions and capital markets execution. See our latest analysis for Oppenheimer Holdings. The leadership change comes as Oppenheimer Holdings’ share price has moved sharply higher in recent months, with a 30 day share...

If you are trying to figure out whether Fair Isaac at around US$1,072 per share is priced attractively or not, the starting point is understanding how its current market value lines up against different valuation checks. The stock has had a mixed run, with a 1.6% decline over the last week, a 16.6% decline over the last month, a 34.7% decline year to date, and a 42.0% decline over the last year, while still showing a 53.5% return over three years and 102.0% over five years. This kind of...

Wondering whether KKR at around US$92.83 is offering value or asking you to pay up? This breakdown will help you stress test what that price really means. The stock has seen mixed returns, with gains of 1.8% over the past week and 3.2% over the past month, set against a year to date return of a 28.0% decline and a 1 year return of an 8.3% decline, while the 3 year and 5 year returns sit at 82.5% and 83.1% respectively. Recent headlines around KKR have focused on its role as a large...

Fortinet recently held its APAC Demo Day – SASE Edition, while analysts continue to highlight an upcoming May 6, 2026 earnings report with expectations of EPS growth and higher revenue compared with last year. With analysts pointing to Fortinet’s consistent record of outperforming earnings forecasts and maintaining a Zacks Rank of #3 (Hold), the company’s ability to potentially exceed expectations again is drawing attention to its evolving mix of security and networking solutions. Next,...

Context for Cohen & Steers (CNS) after recent performance Cohen & Steers (CNS) has drawn fresh attention after a mixed stretch of returns, with modest gains over the past month contrasting with a negative move in the past 3 months and over the past year. See our latest analysis for Cohen & Steers. At a share price of US$64.04, Cohen & Steers has seen short-term share price momentum soften. This follows a 1-month gain of 1.28%, a 90-day share price return decline of 5.88%, and a 1-year total...

Wondering whether TransDigm Group at around US$1,225 per share is still priced for opportunity or already reflecting its strengths? This article walks you through what the current valuation actually says. The stock has returned 5.0% over the last 7 days, while the 30 day and year to date returns of 3.4% decline and 9.8% decline sit against a 0.9% return over the last year and 90.2% and 136.4% returns over 3 and 5 years. Recent coverage has focused on TransDigm Group's position in aerospace...

National Fuel Gas (NFG) has updated its financing toolkit by entering an Amended and Restated Credit Agreement that provides a US$1.3 billion unsecured revolving credit facility, extending liquidity coverage for routine needs and potential acquisitions. See our latest analysis for National Fuel Gas. That expanded credit facility arrives at a time when momentum in National Fuel Gas’s shares has been firm, with a 90-day share price return of 21.26% and a 1-year total shareholder return of...

NRG Energy recently expanded its contracted data center power capacity to about 445 megawatts and closed the LS Power portfolio acquisition, roughly doubling its generation fleet to around 25 gigawatts while updating its 2026 financial guidance. These moves deepen NRG’s role in supplying power to AI and data center customers, while adding a commercial virtual power plant platform that could reshape how it monetizes flexible generation and grid services. We’ll now examine how the LS Power...

Wondering if Oncolytics Biotech at US$1.04 is priced for its potential or already running ahead of itself? This article walks through what the numbers are actually saying about value. The stock shows mixed return figures, with a 7 day return of 8.3%, 30 day return of 2.0%, year to date return of 5.7%, a 1 year return of 108.0%, a 3 year return of 11.9% decline, and a 5 year return of 64.5% decline that some investors may see as a reset in expectations. Recent attention around Oncolytics...

BridgeBio Pharma (NasdaqGS:BBIO) reported long term data for acoramidis (Attruby) in transthyretin amyloid cardiomyopathy, showing sustained efficacy, safety and quality of life outcomes over several years. The company highlighted the role of early and continuous treatment for ATTR-CM patients, citing ongoing unmet medical needs with existing options. BridgeBio submitted a New Drug Application to the US FDA for BBP-418, supported by Phase 3 data in limb-girdle muscular dystrophy type...

Merit Medical Systems (NasdaqGS:MMSI) has acquired View Point Medical, expanding its presence in interventional medical devices. The company has also broadened its distribution agreement with Medtronic, widening access to Merit's products through Medtronic's channels. For investors watching NasdaqGS:MMSI, these moves come as the stock trades around $68.65, with a mixed return profile over recent periods. Shares show an 11.9% return over 5 years, alongside weaker performance over the past 1,...

On 9 April 2026, CoreWeave announced an expanded long-term agreement to supply Meta with AI cloud capacity through December 2032, worth about US$21.00 billion and including early deployments of NVIDIA’s Vera Rubin platform across multiple locations. This multi-year commitment deepens CoreWeave’s role as critical infrastructure for Meta’s AI ambitions while further diversifying its large-scale cloud customer base. We’ll now examine how this expanded Meta agreement, and its long-term revenue...

FedRAMP milestone puts Clear Secure in focus Clear Secure (YOU) is drawing fresh investor attention after its CLEAR1 platform received a FedRAMP "In Process" designation at the Moderate level, a key milestone for working with federal agencies. See our latest analysis for Clear Secure. While the FedRAMP news has put Clear Secure back on the radar, the share price tells its own story, with a 30 day share price return of 6.78% and a 90 day share price return of 34.37%, feeding into a 1 year...